Home » Approved Conditions » Multiple Sclerosis (MS)

Multiple Sclerosis (MS) in New York

Studies have shown that medicinal cannabis can help treat the symptoms of Multiple Sclerosis (MS).

Multiple Sclerosis (MS)

Multiple sclerosis remains a mystery and presents in various forms. This makes a rule-out diagnosis necessary to eliminate similar conditions before identifying MS. Magnetic Resonance Imaging (MRI) helps identify the areas of the brain and spinal cord where lesions appear.

Malfunctioning immune cells attack body systems and cause attacks (flares) in a person who copes with issues of mobility and cognition already. Lesions identify locations where the layer of protection (myelin) covering a nerve came under attack and no longer functions due to deterioration. The lesions will interrupt or block communication between the nerve and the area it services.

Symptoms of  Multiple Sclerosis

Nerves that deteriorate in the brain will affect each individual differently.

Various signs and symptoms could appear such as the following:

  • Vertigo – a specific type of dizziness
  • Blurry or double vision
  • Complete loss of vision in one eye at time – with pain
  • Fatigue
  • Stuttering or slurred speech
  • Surging electrical sensations, especially when bending the neck forward
  • Numb or weak limbs on one side of the body (or legs and trunk)
  • Pain and tingling in various parts of the body
  • Tremors, unsteady walking, and lack of coordination
  • Bladder and bowel malfunctions

Medical Marijuana as Part of a Multiple Sclerosis Treatment Plan

Cannabis has been widely used to treat MS symptoms for many years with significant patient-reported success. Citiva Medical has designed specific cannabinoid ratio medications which correspond to specific symptoms of MS such as spasticity, spasms, bladder problems, tremors, pain, and insomnia.

The State of New York has a high number of MS patients, and we look forward to beginning observational trials surrounding the effects of our specialized MS-targeted medicines.

Research on Multiple Sclerosis and Cannabis Based Treatments

For more information on medicinal cannabis being used to treat MS, please click on the following links:

Multiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo-controlled, crossover study

Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis

Oromucosal Delta-9–tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

Cannabis use in patients with multiple sclerosis

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

Randomized controlled trial of cannabis-based medicinal extracts (CBME) in central neuropathic pain due to multiple sclerosis

Cannabis use as described by people with multiple sclerosis

Safety, tolerability, and efficacy of orally administered cannabinoids in MS

Delta-9-THC in the treatment of spasticity associated with multiple sclerosis

To find out more about Citiva Medical, contact us today.